Search Results

Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin

• Authors : Srisrattakarn A; Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand; Chaiyapoke C

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacology ; Cefotaxime/Cefotaxime/Cefotaxime/*pharmacology ; Imipenem/Imipenem/Imipenem/*pharmacology

• Source: Turkish journal of medical sciences [Turk J Med Sci] 2021 Aug 30; Vol. 51 (4), pp. 2150-2158. Date of Electronic Publication: 2021 Aug 30.Publisher: Scientific and Technical Research Council of Turkey Country of Publication: Turkey NLM ID: 9441758 Publication Model: Electronic Cited Medium:

Record details

Additive Effect of MCP in Combination with Cefotaxime Against Staphylococcus aureus.

• Authors : Dahdouh E; Faculty of Medicine, University of Balamand, El-Koura. Lebanon.; El-Khatib S

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacology ; Cefotaxime/Cefotaxime/Cefotaxime/*pharmacology ; Pectins/Pectins/Pectins/*pharmacology

• Source: Medicinal chemistry (Shariqah (United Arab Emirates)) [Med Chem] 2017; Vol. 13 (7), pp. 682-688.Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101240303 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Agricola

Record details

Case of bullous impetigo with enormous bulla developing into staphylococcal scalded skin syndrome.

• Authors : Bae SH; Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea.; Lee JB

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Blister/Blister/Blister/*pathology ; Cefotaxime/Cefotaxime/Cefotaxime/*therapeutic use

• Source: The Journal of dermatology [J Dermatol] 2016 Apr; Vol. 43 (4), pp. 459-60. Date of Electronic Publication: 2015 Nov 25.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Cefotaxime-heparin lock prophylaxis against hemodialysis catheter-related sepsis among Staphylococcus aureus nasal carriers.

• Authors : Saxena AK; Al-Rahba Hospital-Johns Hopkins Medicine International, Abu Dhabi, United Arab Emirates. ; Panhotra BR

Subjects: Antibiotic Prophylaxis*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage

• Source: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia [Saudi J Kidney Dis Transpl] 2012 Jul; Vol. 23 Publisher: Medknow Country of Publication: Saudi Arabia NLM ID: 9436968 Publication Model: Print Cited Medium: Print ISSN: 1319-2442 (Print)

Record details

Cefodizime: effects of sub-inhibitory concentrations on adhesiveness and bacterial morphology of Staphylococcus aureus and Escherichia coli: comparison with cefotaxime and ceftriaxone.

• Authors : Braga PC; Centre for Respiratory Pharmacology, School of Medicine, University of Milan, Italy.; Dal Sasso M

Subjects: Bacterial Adhesion/Bacterial Adhesion/Bacterial Adhesion/*drug effects ; Cefotaxime/Cefotaxime/Cefotaxime/*analogs & derivatives ; Cephalosporins/Cephalosporins/Cephalosporins/*pharmacology

• Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 1997 Jan; Vol. 39 (1), pp. 79-84.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Print ISSN: 0305-7453

Record details

The combination effect of Korean red ginseng saponins with kanamycin and cefotaxime against methicillin-resistant Staphylococcus aureus.

• Authors : Sung WS; Department of Microbiology, College of Natural Sciences, Kyungpook National University, Daegu, South Korea.; Lee DG

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacology ; Cefotaxime/Cefotaxime/Cefotaxime/*pharmacology ; Ginsenosides/Ginsenosides/Ginsenosides/*pharmacology

• Source: Biological & pharmaceutical bulletin [Biol Pharm Bull] 2008 Aug; Vol. 31 (8), pp. 1614-7.Publisher: Pharmaceutical Society of Japan Country of Publication: Japan NLM ID: 9311984 Publication Model: Print Cited Medium: Print ISSN:

Record details

[Evaluation of cefoxitin and cefotaxime screening plates for the detection of methicillin-resistance in Staphylococcus aureus].

• Authors : Lorenz R; Sección Microbiología, Laboratorio Central, Hospital Dr. José María Cullen Santa Fe, Argentina. ; Méndez Ede L

Subjects: Methicillin Resistance*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacology ; Cefotaxime/Cefotaxime/Cefotaxime/*pharmacology

• Source: Revista Argentina de microbiologia [Rev Argent Microbiol] 2006 Jul-Sep; Vol. 38 (3), pp. 152-4.Publisher: Asociación Argentina de Microbiología Country of Publication: Argentina NLM ID: 8002834 Publication Model: Print Cited Medium: Print

Record details

Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbits.

• Authors : Chavanet P; Service des Maladies Infectieuses et Tropicales, Hôpital du Bocage, Dijon, France.; Muggeo E

Subjects: Cefotaxime/Cefotaxime/Cefotaxime/*therapeutic use ; Fosfomycin/Fosfomycin/Fosfomycin/*therapeutic use ; Staphylococcal Infections/Staphylococcal Infections/Staphylococcal Infections/*drug therapy

• Source: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 1990 Apr; Vol. 9 Publisher: Springer Country of Publication: Germany NLM ID: 8804297 Publication Model: Print Cited Medium: Print ISSN: 0934-9723 (Print)

Record details

In vitro antibacterial activity of cefotaxime and desacetylcefotaxime, alone or in combination, against gram-positive cocci.

• Authors : Cruciani M; Institute of Infectious Diseases, University of Verona, Italy.; Navarra A

Subjects: Cefotaxime/Cefotaxime/Cefotaxime/*analogs & derivatives ; Cefotaxime/Cefotaxime/Cefotaxime/*pharmacology ; Staphylococcus aureus/Staphylococcus aureus/Staphylococcus aureus/*drug effects

• Source: Drugs under experimental and clinical research [Drugs Exp Clin Res] 1990; Vol. 16 (11), pp. 565-8.Publisher: Bioscience Ediprint Country of Publication: Switzerland NLM ID: 7802135 Publication Model: Print Cited Medium: Print ISSN: 0378-6501

Record details